Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction.

Jianguo Sun,Guangji Wang,Xie Haitang,Li Hao,Pan Guoyu,ian g tucker
DOI: https://doi.org/10.1016/j.jpba.2004.12.007
IF: 3.571
2005-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:Ginseng saponins isolated from ginseng, have been regarded as the principal constituents responsible for the biological activities. The aim of this study was to set up a liquid chromatography–mass spectrometry (LC–MS) method for simultaneously determine the concentration of Ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol (PPT) in rat plasma so as to study the pharmacokinetics of Rg1 after intraveneous (i.v.) and intragastric gavage (i.g.) administration. One hundred microliters or 1.0ml of rat plasma samples from i.v. or i.g. treated rats were used respectively for analysis. After solid-phase extraction (SPE) and high performance liquid chromatography (HPLC) separation, the chloride adduct anions [M+Cl]− of Rg1, Rh1 and PPT were analyzed by LC–MS in selected ions monitoring (SIM) mode. Rg1 could be determined by this LC–MS method over the ranges of 1.56–250ng/ml and 250–20,000ng/ml with the correlation coefficients of 0.999 and 0.9998, respectively. The detection limits (LOD) of this method was 20pg (S/N>3) for Rg1, 100pg for Rh1 and 10pg for PPT. Chromatographic separation was achieved in less than 8mins. The method has been used for the pharmacokinetic study of Rg1 in rats.
What problem does this paper attempt to address?